President, CEO and Director
During the 12 years prior to joining BioCorRx® in June of 2013, Brady Granier had been involved in sales management, media sales and business development. Mr. Granier was employed at Clear Channel Media & Entertainment ("CCME"), where he had served in several positions from Account Executive to Director of Business Development and Local Sales Manager. He has also served as the Healthcare Category Manager for the Los Angeles division of CCME, the largest media company in the United States. During his tenure at CCME and other media companies, he worked on marketing campaigns for local businesses and physicians, as well as for national brands such as Neutrogena, New Line Cinema, Paramount Pictures, Samsung, AT&T, Coke, Dr. Pepper, Hansen's, Honda, MGM, Universal Studios and more. He also managed endorsements on the radio for Ryan Seacrest. In 2006, He received the coveted Pinnacle Award from CCME for being the top sales executive in the Western region. While serving as Director of Business Development, Mr. Granier grew new business by 49% in his first year in that role.
Granier was born and raised in the heart of Cajun Country in Southeast Louisiana where he started working at the age of 11 to help support his single mother and younger brother. After graduating with honors from high school, he attended college at Nicholls State University in Thibodaux, LA. He earned his Bachelor of Science degree in Nursing in 1995 and was a member of Sigma Theta Tau Honor Society and Phi Kappa Theta. During his nursing career, he specialized in the critical care areas of ER/ICU/CCU and CICU. He also moonlighted as a home health nurse, critical care air transport nurse and TV studio set medic. In 1996, he moved to California as a travel nurse and spent most of his remaining years in healthcare as the charge nurse in the emergency room at White Memorial Hospital in downtown Los Angeles. Mr. Granier continues to reside in the Los Angeles area with his family. He has also been a volunteer with Big Brothers of America.
CFO, COO and Director
Lourdes Felix joined BioCorRx® in October 2012. Ms. Felix has been instrumental in assisting in capital procurement and implementing an audit committee. Ms. Felix is a corporate finance executive offering more than 15 years of combined experience in public accounting and in the private sector in building, leading and advising corporations through complex restructurings.
Ms. Felix is thoroughly experienced in guiding companies to greater efficiency and profitability. Strong SEC expertise and knowledge of SOX requirements. She worked with private and public SEC reporting companies. She was the Controller for a public accounting firm for more than 7 years and was responsible for the operations and financial management of regional offices. Her experience includes a wide variety of industries including advertising, marketing, non-profit organizations, medical practices, mortgage banking, manufacturing and SEC reporting companies. Ms. Felix is an excellent leader with a track record of documented contributions leading to improved financial performance, heightened productivity and enhanced internal controls.
Ms. Felix is very active in the Hispanic community and speaks fluent Spanish. Ms. Felix holds a Bachelor of Science degree in Business Management and Accounting from University of Phoenix.
Dr. Balbir S. Brar
Senior VP of Drug Development
Dr. Brar has over 25 years of experience in drug and device development, including worldwide regulatory submissions for over 50 INDs, 510(k)s and 505(b)(2)s, as well as approval of 8 NDAs for drugs currently on the market. Dr. Brar’s experience includes working with major pharmaceutical companies such as Lederle/Wyeth, where he was instrumental in the development of Azmacort for asthma, as well as topical Aristocort. At GlaxoSmithKline, as Director of Drug Safety, Dr. Brar participated in the development of Tazarotene. At Allergan, as VP of Drug Safety, he made major contributions towards the development, regulatory submission, and approval of Botox, Alphagan, Lumigan, Restasis, Ofloxacin, Azelex, and Avage.
For the past 10 years Dr. Brar has played a leadership role for several early stage biotechnology companies in the fields of nephropathy, oncology, ophthalmology, dermatology, pain, and cardiology. During this time, Dr. Brar served on the Board of Directors, and acted as President, EVP R&D, and Chief Technology Officer. Dr. Brar has a Ph.D. in Toxicology/Pathology from Rutgers University and D.V.M. from a university in India with finance training from Harvard Business School.
VP of Operations
Welch was a founder and Director of Operations at TAK Management from 2012 until 2015. TAK Management was responsible for the streamlining of clinical and financial operations for Start Fresh Alcohol and Opioid Recovery Clinic Inc. His responsibilities included placement and training of key personnel, billing, coding, and collections and establishing and maintaining relationships with outside vendors and physicians. Mr. Welch led a team that completely reorganized clinic operations. Tom’s responsibilities included Implementation of policies and procedures as well as creation of standard practice protocols integrated in to multiple locations. Additionally, Tom Implemented traditional media and Social Marketing strategies. Tom was also successful in negotiating reimbursement with major private insurance corporations across the U.S.
Prior to his tenure with TAK Management, Mr. Welch had been involved in the identifying and placement of talented executive level candidates nationwide in healthcare since 1999. In addition to doing both temporary and permanent placement as an Executive Healthcare recruiter, he had been engaged in consulting in the long term care, acute care, and rehab care marketplace. Mr. Welch created Benchmark Consulting Group LLC in 2001 in Los Angles California and expanded into Dallas Texas in 2005. He has been actively involved in assisting in infrastructure creation including, front and back office management, billing and coding personnel, clinical management and executive teams. Tom was responsible for negotiating multiple partnership agreements and contracts with major medical corporations and both the Military and Veterans Administration.
Welch started his career in Healthcare in Omaha Nebraska where he supervised the medivan program while training for his emergency medical technician license with Eastern Ambulance.
Dr. David Gastfriend
In his prior role as Vice President at Alkermes, Dr. Gastfriend worked on pivotal efficacy studies and research on effectiveness, health services, criminal justice systems and health economics. Dr. Gastfriend has accrued extensive experience in the field of addiction treatment at institutions such as Massachusetts General Hospital Department of Psychiatry, The Treatment Research Institute and the American Society of Addiction Medicine.
Dr. George Fallieras
Dr. George N. Fallieras comes from a family of physicians. Dr. Fallieras grew up in Tampa, Florida, and graduated Phi Beta Kappa from the University of Florida. He obtained his M.D. from the University of Tennessee, and did his residency training in New Orleans at the Tulane Health Science Center/Charity Hospital. Dr. Fallieras is double board certified in both Internal Medicine and Pediatrics. He has extensive emergency room, hospital inpatient, ICU, inpatient and outpatient detoxification, and outpatient recovery experience. He has served as the Medical Director for multiple large Inpatient Hospitalist programs. He is passionate about international medicine and serves on twice yearly missions trips to rural Dominican Republic and Port-au-Prince, Haiti. Dr. Fallieras has served as expert commentary on multiple news, television, and radio outlets.
Dr. Fallieras has always taken a keen interest in addiction medicine, in particular alcohol and opiate abuse. He has provided care to countless alcoholic and addicted patients in the acute hospital setting. He has seen innumerable cases of suffering individuals literally drinking themselves to death. With dread, he has made those difficult calls to parents notifying them of their child’s overdose and death. He has witnessed the profound physical and emotional burden that alcohol and drug abuse inflicts upon the individual and their families. He has seen the disappointment and shame in the eyes of very good and determined individuals who desperately want to quit drinking but are held down by the firm grasp of addiction. Like most people, he has first-hand knowledge of family members and loved ones who have endured this common struggle.
As a medical director for BioCorRx, he has established ethical and effective protocols. He believes addiction is a chronic “brain disease” and requires comprehensive treatment including physical and laboratory evaluation, vitamin and nutrient repletion, nutritional support, safe and comfortable detoxification, medications to eliminate or reduce cravings, psychological attention, emotional regulation, behavioral modification to identify/address/avoid/extinguish triggers, and long-term attention and surveillance (group setting and support most effective).